PH12015502844B1 - Mammalian milk osteopontin for enhancing immune responsiveness - Google Patents
Mammalian milk osteopontin for enhancing immune responsivenessInfo
- Publication number
- PH12015502844B1 PH12015502844B1 PH12015502844A PH12015502844A PH12015502844B1 PH 12015502844 B1 PH12015502844 B1 PH 12015502844B1 PH 12015502844 A PH12015502844 A PH 12015502844A PH 12015502844 A PH12015502844 A PH 12015502844A PH 12015502844 B1 PH12015502844 B1 PH 12015502844B1
- Authority
- PH
- Philippines
- Prior art keywords
- mammalian milk
- mammal
- infectious disease
- milk osteopontin
- active
- Prior art date
Links
- 102000004264 Osteopontin Human genes 0.000 title abstract 4
- 108010081689 Osteopontin Proteins 0.000 title abstract 4
- 239000008267 milk Substances 0.000 title abstract 4
- 210000004080 milk Anatomy 0.000 title abstract 4
- 235000013336 milk Nutrition 0.000 title abstract 4
- 230000002708 enhancing effect Effects 0.000 title abstract 3
- 230000004043 responsiveness Effects 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 5
- 208000035473 Communicable disease Diseases 0.000 abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Marine Sciences & Fisheries (AREA)
- Dispersion Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361843185P | 2013-07-05 | 2013-07-05 | |
| EP13175267 | 2013-07-05 | ||
| PCT/EP2014/064339 WO2015001092A1 (en) | 2013-07-05 | 2014-07-04 | Mammalian milk osteopontin for enhancing immune responsiveness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PH12015502844A1 PH12015502844A1 (en) | 2016-03-28 |
| PH12015502844B1 true PH12015502844B1 (en) | 2016-03-28 |
Family
ID=48740972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12015502844A PH12015502844B1 (en) | 2013-07-05 | 2015-12-21 | Mammalian milk osteopontin for enhancing immune responsiveness |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US9956283B2 (enExample) |
| EP (1) | EP3016673B1 (enExample) |
| JP (1) | JP6509833B2 (enExample) |
| KR (1) | KR102307002B1 (enExample) |
| CN (1) | CN105407910B (enExample) |
| AU (1) | AU2014286123B2 (enExample) |
| BR (1) | BR112016000067B1 (enExample) |
| CA (1) | CA2916821C (enExample) |
| CL (1) | CL2015003803A1 (enExample) |
| DK (1) | DK3016673T3 (enExample) |
| EA (1) | EA034654B1 (enExample) |
| ES (1) | ES2656474T3 (enExample) |
| MX (1) | MX369925B (enExample) |
| NZ (1) | NZ715430A (enExample) |
| PH (1) | PH12015502844B1 (enExample) |
| PL (1) | PL3016673T3 (enExample) |
| PT (1) | PT3016673T (enExample) |
| WO (1) | WO2015001092A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210236605A1 (en) * | 2018-04-25 | 2021-08-05 | Health And Happiness (H&H) Hong Kong Limited | Combinations of osteopontin and 2'-fucosyllactose for use as medicaments |
| US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
| CN113424962A (zh) * | 2020-09-21 | 2021-09-24 | 黑龙江飞鹤乳业有限公司 | 提高免疫力的营养组分、含有其的食品或保健品及其用途 |
| CA3216462A1 (en) * | 2021-04-20 | 2022-10-27 | University Of Cincinnati | A vaccine adjuvant for infectious diseases |
| CN113475720B (zh) * | 2021-06-15 | 2023-07-25 | 合生元（广州）健康产品有限公司 | 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用 |
| WO2023144416A1 (en) | 2022-01-31 | 2023-08-03 | Société des Produits Nestlé S.A. | Compositions comprising osteopontin (opn) |
| CN117337994A (zh) * | 2023-10-11 | 2024-01-05 | 黑龙江飞鹤乳业有限公司 | 功能性组合物及该组合物的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998056405A1 (en) * | 1997-06-10 | 1998-12-17 | Whitehead Institute For Biomedical Research | A method of modulating immune response with osteopontin |
| WO1998056404A1 (en) * | 1997-06-11 | 1998-12-17 | Acorda Therapeutics | Cns neuroregenerative compositions and methods of use |
| EP1175223A2 (en) * | 1999-04-15 | 2002-01-30 | Children's Medical Center Corporation | Methods and compositions for modulating an immune response |
| NZ519492A (en) | 2000-01-07 | 2003-03-28 | Arla Foods Amba | A process for isolation of osteopontin from milk |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| US7205398B2 (en) * | 2002-05-24 | 2007-04-17 | Schering-Plough Animal Health Corporation | Eta-1 gene and methods for use |
| US20050287247A1 (en) * | 2003-09-18 | 2005-12-29 | Sorensen Esben S | Infant formula |
| RU2379975C2 (ru) * | 2003-09-18 | 2010-01-27 | Арла Фудс Амба | Добавка в состав для детского питания |
| KR20090123115A (ko) * | 2008-05-27 | 2009-12-02 | 한국생명공학연구원 | 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법 |
| WO2012117119A1 (en) * | 2011-03-03 | 2012-09-07 | Arla Foods Amba | Method for isolating osteopontin using feeds containing cmp or casein species |
| EP2788015A1 (en) | 2011-12-07 | 2014-10-15 | Arla Foods Amba | Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants |
-
2014
- 2014-07-04 ES ES14735964.0T patent/ES2656474T3/es active Active
- 2014-07-04 AU AU2014286123A patent/AU2014286123B2/en active Active
- 2014-07-04 BR BR112016000067-6A patent/BR112016000067B1/pt active IP Right Grant
- 2014-07-04 WO PCT/EP2014/064339 patent/WO2015001092A1/en not_active Ceased
- 2014-07-04 DK DK14735964.0T patent/DK3016673T3/da active
- 2014-07-04 CN CN201480038124.7A patent/CN105407910B/zh active Active
- 2014-07-04 PT PT147359640T patent/PT3016673T/pt unknown
- 2014-07-04 NZ NZ715430A patent/NZ715430A/en unknown
- 2014-07-04 JP JP2016522645A patent/JP6509833B2/ja active Active
- 2014-07-04 US US14/903,049 patent/US9956283B2/en active Active
- 2014-07-04 KR KR1020167002892A patent/KR102307002B1/ko active Active
- 2014-07-04 CA CA2916821A patent/CA2916821C/en active Active
- 2014-07-04 MX MX2016000107A patent/MX369925B/es active IP Right Grant
- 2014-07-04 EP EP14735964.0A patent/EP3016673B1/en active Active
- 2014-07-04 PL PL14735964T patent/PL3016673T3/pl unknown
- 2014-07-04 EA EA201690057A patent/EA034654B1/ru not_active IP Right Cessation
-
2015
- 2015-12-21 PH PH12015502844A patent/PH12015502844B1/en unknown
- 2015-12-31 CL CL2015003803A patent/CL2015003803A1/es unknown
-
2018
- 2018-04-04 US US15/945,517 patent/US10772955B2/en not_active Ceased
-
2022
- 2022-01-12 US US17/573,707 patent/USRE50281E1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160030960A (ko) | 2016-03-21 |
| EA201690057A1 (ru) | 2016-07-29 |
| MX2016000107A (es) | 2016-06-07 |
| EA034654B1 (ru) | 2020-03-03 |
| AU2014286123B2 (en) | 2019-02-28 |
| JP2016529217A (ja) | 2016-09-23 |
| US9956283B2 (en) | 2018-05-01 |
| CN105407910B (zh) | 2019-12-03 |
| US20180289798A1 (en) | 2018-10-11 |
| PT3016673T (pt) | 2018-01-30 |
| NZ715430A (en) | 2022-01-28 |
| DK3016673T3 (da) | 2018-01-29 |
| PL3016673T3 (pl) | 2018-04-30 |
| CN105407910A (zh) | 2016-03-16 |
| US10772955B2 (en) | 2020-09-15 |
| BR112016000067A2 (enExample) | 2017-09-05 |
| PH12015502844A1 (en) | 2016-03-28 |
| MX369925B (es) | 2019-11-25 |
| CA2916821A1 (en) | 2015-01-08 |
| USRE50281E1 (en) | 2025-01-28 |
| US20160136268A1 (en) | 2016-05-19 |
| JP6509833B2 (ja) | 2019-05-08 |
| ES2656474T3 (es) | 2018-02-27 |
| CA2916821C (en) | 2023-10-03 |
| EP3016673A1 (en) | 2016-05-11 |
| EP3016673B1 (en) | 2017-10-25 |
| BR112016000067B1 (pt) | 2022-08-30 |
| KR102307002B1 (ko) | 2021-10-05 |
| AU2014286123A1 (en) | 2016-01-21 |
| CL2015003803A1 (es) | 2016-08-05 |
| WO2015001092A1 (en) | 2015-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015502844A1 (en) | Mammalian milk osteopontin for enhancing immune responsiveness | |
| NI201800052A (es) | Anticuerpos que neutraliza el virus respiratorio sincitial humano | |
| WO2014176128A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
| WO2014113490A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| PT2643345T (pt) | Péptidos imunogénicos para utilizar na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunitárias a alofatores, doenças alérgicas, tumores, rejeição de enxertos e respostas imunitárias contra vetores virais usados para a terapêutica de genes ou na vacinação genética | |
| EP4272750A3 (en) | Protein antigens that provide protection against pneumococcal colonization and/or disease | |
| GEAP202115055A (en) | Anti-cd27 antibodies | |
| MX2013004817A (es) | Enfermedad inflamatoria. | |
| WO2013106834A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| EA202090699A2 (ru) | Композиции, содержащие буфер, вакцины, которые содержат композиции, содержащие буфер, и пути их применения | |
| EA201590829A1 (ru) | Новые мукозные адъюванты и системы доставки | |
| MX2013014485A (es) | Vacuna bovinas y metodos. | |
| EA201790507A1 (ru) | Способы и композиции для усиления иммунных ответов | |
| PH12015501716A1 (en) | Anti-mycoplasma spp. subunit vaccine | |
| CY1119957T1 (el) | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| WO2015054678A3 (en) | Human papilloma virus therapeutic vaccine | |
| PH12014501795A1 (en) | Rota virus subunit vaccines and methods of making and use thereof | |
| NZ704188A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
| WO2013173256A3 (en) | New and improved influenza vaccines | |
| GB2515222A (en) | Use of flagellin as a vaccine | |
| MX363044B (es) | Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos. | |
| MX367074B (es) | Inulina y formulaciones de acetato de inulina. | |
| WO2011084967A3 (en) | Methods and compositions for providing protective immunity in the elderly |